BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

santarus Pages on BioPortfolio:

BioPortfolio - Santarus
Santarus - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/9157-Santarus.html...

Biotechnology News ZEGERID Search
Santarus Prevails on Claims Disputed by Par Pharmaceutical at Markman Hearing - Santarus, Inc. ... Santarus Reports Third Quarter 2008 Financial Results ...
http://www.bioportfolio.co.uk/ZEGERID-news.htm...

Santarus Zegerid - Fast-acting formulation gaining momentum in GERD
Santarus Zegerid - Fast-acting formulation gaining momentum in GERD Following the lackluster 2004 launch of an oral suspension formulation of Santarus' lead
...
http://www.bioportfolio.com/cgi-bin/acatalog/Santarus_Zegeri...

Biotechnology News Hearing Loss Search
Santarus Prevails on Claims Disputed by Par Pharmaceutical at Markman Hearing Business Editors/Health/Medical Writers SAN DIEGO--(BUSINESS WIRE)--November 5
...
http://www.bioportfolio.co.uk/Hearing%20Loss-news.htm...

BioPortfolio - BioPortfolio - Santarus
BioPortfolio - Santarus - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/9157/www.sa...

Biotechnology News Stargardt's acucela. rebamipid. otsuka. kubota ...
Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company, today reported financial and operating results for the quarter ended September 30, 2008. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - Santarus - Profile
Santarus Prevails on Claims Disputed by Par Pharmaceutical at Markman Hearing ... Genetic Engineering News: Nov 6 2008 12:46AM Matching: santarus ...
http://www.bioportfolio.com/biocorporate/9157-Santarus.pdf...

Biotechnology News lawsuit legal win. court. drugmak. top. limit ...
Santarus Prevails on Claims Disputed by Par Pharmaceutical at Markman Hearing - Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company, ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - Santarus
Santarus Zegerid - Fast-acting formulation gaining momentum in GERD ... Santarus - Entry on Bioportfolio's Biocorporate Database. ...
http://www.bioportfolio.com/search/Santarus.html...

santarus and depomed announce us promotion agreement for glumetza ...
healthcare sales & marketing network:
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

Results from other life science and pharmaceutical sites:

BioSpace - Santarus Inc. News, Search Jobs, Events
Santarus is a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients ...
http://www.biospace.com/company_profile.aspx?CompanyId=79504...

Santarus Commences GLUMETZA Promotion: Financial News - Yahoo! Finance
Santarus Commences GLUMETZA Promotion. - SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ:SNTS - News), a specialty pharmaceutical company, ...
http://biz.yahoo.com/bw/081010/20081010005069.html?.v=1...

BioPortfolio - Santarus
Santarus - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/9157-Santarus.html...

Santarus Prevails on Claims Disputed by Par Pharmaceutical at ...
Santarus Prevails on Claims Disputed by Par Pharmaceutical at Markman Hearing. - SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ:SNTS - News), ...
http://biz.yahoo.com/bw/081105/20081105006344.html?.v=1...

Santarus Inc. Terminates Co-promotion Agreement with Otsuka ...
Under the co-promotion agreement, Otsuka America has provided promotional support in the U.S. related to Santarus’ ZEGERID® (omeprazole/sodium bicarbonate
) ...
http://www.biospace.com/news_story.aspx?NewsEntityId=92824...

Live Call: Santarus, Inc. Earnings Conference Call (Q3 2008 ...
Learn when companies announce their quarterly, annual earnings as well as other types of announcements. Listen to the conference call and remind yourself by ...
http://biz.yahoo.com/cc/4/98234.html...

News: Santarus Prevails on Claims Disputed by Par Pharmaceutical ...
Santarus Prevails on Claims Disputed by Par Pharmaceutical at Markman Hearing. Genetic Engineering & Biotechnology News - Biotechnology from Bench to ...
http://www.genengnews.com/news/bnitem.aspx?name=44889017&chi...

Santarus to Hold Third Quarter 2008 Financial Results Conference ...
Santarus to Hold Third Quarter 2008 Financial Results Conference Call on November 3. - SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ:SNTS - News),
...
http://biz.yahoo.com/bw/081021/20081021005446.html?.v=1...

Santarus Zegerid - Fast-acting formulation gaining momentum in GERD
Santarus Zegerid - Fast-acting formulation gaining momentum in GERD Following the lackluster 2004 launch of an oral suspension formulation of Santarus' lead
...
http://www.bioportfolio.com/cgi-bin/acatalog/Santarus_Zegeri...

Santarus Reports Third Quarter 2008 Financial Results: Financial ...
3 Nov 2008 ... Santarus Reports Third Quarter 2008 Financial Results. - SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ:SNTS - News), ...
http://biz.yahoo.com/bw/081103/20081103006432.html?.v=1...

Google Custom Search

Search
  

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.